Paul is a Professor in the Department of Social Policy at LSE. He is a visiting professor in the Division of Surgery, Department of Surgery & Cancer at Imperial College London.
More details available at http://pauldolan.co.uk
There are two main themes to my work. The first focuses on developing measures of happiness subjective well-being that can be used in policy, particularly in the valuation of non-market goods and in 'joining up' the impact of changes in health, crime, the environment etc. The second considers ways in which the lessons from behavioural economics can be used to understand and change individual behaviour. This work is focussing on the important role that situational factors play in influencing our behaviour. For both areas, I am interested in how field experiments can be used to provide us with robust evidence for policy appraisal.
1. Dolan P, Elliott A, Metcalfe R and Vlaev I, Influencing financial behaviour: from changing minds to changing contexts, Journal of Behavioral Finance.
2. Dolan P, Thinking about it: thoughts about health and valuing QALYs, Health Economics.
3. Metcalfe R, Powdthavee N and Dolan, P, Destruction and distress: A quasi-experiment to show the effects of the September 11 attacks on mental well-being in the UK, Economic Journal, 121, F81-F103, 2011.
4. Bradford D and Dolan P, Getting used to it: Adaptive global utility model, Journal of Health Economics, 29, 6, 811-820, 2010.
5. Dolan P and Metcalfe, Oops I did it again: the double focussing effect in wellbeing reports, Journal of Economic Psychology, 31, 732-737, 2010.
6. Dolan P and Tsuchiya A, Determining the parameters in social welfare function using stated preference data: an application to health, Applied Economics.
7. White M and Dolan P, Accounting for the richness of our daily activities, Psychological Science, 20, 8, 1000-1008, 2009.
8. Dolan P, Lee H, King D, Metcalfe R. Valuing health directly, British Medical J. 339, b2577, 2009.
9. Dolan P and Tsuchiya A, The social welfare function and individual responsibility: Some theoretical issues and empirical evidence, J. Health Economics., 28, 210-220, 2009.
10. Ratcliffe J, Bekker H, Dolan P, Edlin R, The trade-off between access, equity and cost-effectiveness,Health Policy, 90, 45-57, 2009.
11. Dolan P and Peasgood T, Measuring well-being for public policy: preferences or experiences?, J. Legal Studies, 37, 5-31, 2008.
12. Tsuchiya A and Dolan, P, Equality of what in health? Distinguishing between outcome egalitarianism and gain egalitarianism, Health Economics, 18, 147-159, 2008.
13. Dolan P, Metcalfe R, Christianson M, Munro V, Valuing lives and life years: anomalies, implications and an alternative Health Economics, Policy and Law, 3, 277-300, 2008.
14. Dolan P and Kahneman D, Interpretations of utility and their implications for the valuation of health,Economic Journal., 118 (525), 215–234, 2008.
15. Dolan P, Peasgood T, and White M. Do we really know what makes us happy? A review of the economic literature on the factors associated with subjective well-being, J. Economic Psychology 29, 94–122, 2008.
16. Dolan P, Developing methods that really do measure the Q in the QALY, Health Economics, Policy and Law, 3, 1, 69-78, 2008.
17. Dolan P, Edlin R, Tsuchiya A and Wailoo A, It ain’t what you do, it’s the way that you do it: Characteristics of procedural justice and their importance in social decision making, J. of Economic Behavior and Organization 64, 1, 157-170, 2007.
18. Dolan P, Netten A, Shapland J, Tsuchiya A, Developing a preference-based measure of public security,International Review of Victimology, 14, 2, 2007.
19. Dolan P and Moore S, Valuing the losses in well-being from crime and the fear of crime using experienced utility, International Review of Victimology , 14, 2, 2007.
20. Dolan P and White M, How can measures of subjective well-being be used to inform public policy?,Perspectives on Psychological Science, 2, 1, 71-85, 2007.
21. Dolan P and Tsuchiya A Do NHS clinicians and members of the public share the same views about reducing inequalities in health?, Social Science and Medicine 64, 12, 2499-2503, 2007.
22. Dolan P and Peasgood T, Estimating the economic and social costs of the fear of crime, British J. of Criminology 47, 121-132, 2007.
23. Brazier J, Dolan P, Karampela K and Taylor I, Does the whole equal the sum of the parts? Patient-assigned utility scores for IBS-related health states and profiles, Health Economics, 15, 543-551, 2006.
24. Dolan P and White M, Dynamic well-being: connecting what we anticipate with what we experience,Social Indicators Research, 75 (2) 303-333, 2006.
25. Dolan P and Tsuchiya A, Health priorities and public preferences: the relative importance of past health experience and future health prospects, J. Health Economics, 24, 4, 703-714, 2005.
26. Tsuchiya A, san Miguel L, Edlin R, Wailoo A and Dolan, P, Procedural justice in public health care resource allocation, J. of Health Economics and Policy 4, 119-127, 2005.
27. Karnon J, Tsuchiya A, Dolan P, Using a relativities approach to value the prevention of non-fatal work-related accidents, Health Economics, 14, 11, 1103-1115, 2005.
28. Dolan P, Shaw R, Tsuchiya A and Williams A, QALY maximisation and people’s preferences: A methodological review of the literature, Health Economics. 14, 2, 197-208, 2005.
29. Brazier J, Akehurst R, Brennan A, Dolan P, Claxton K, McCabe C, Sculpher M, Tsuchyia A Should patients have a greater role in valuing health states? Applied Health Economics and Health Policy, 4:201-8, 2005.
30. Tsuchiya A and Dolan P, The QALY model and individual preferences: A systematic review of the literature, Medical Decision Making. 25, 54, 460-467, 2005.
31. Dolan P, Loomes G, Peasgood T and Tsuchiya A, Estimating the intangible victim costs of violent crime, British J. Criminology 45, 958-76, 2005.
32. Dolan P and Jones M, Explaining attitudes towards ambiguity: an experimental test of the comparative ignorance hypothesis, Scottish J. Pol. Econ. 51, 3, 281-301, 2004.
33. Roberts J and Dolan P, To what extent do people prefer health states with higher values? A note on evidence from the EQ-5D valuation set, Health Economics, 13, 7, 733-737, 2004.
34. Bryan S and Dolan P, Discrete choice experiments in health economics: for better or for worse?,European J. Health Economics, 5, 3, 199-202, 2004.
35. Dolan P and Shaw R, A note on a discussion group study of public preferences regarding priorities in the allocation of donor kidneys, Health Policy, 68, 31-36, 2004.
36. Greiner W et al, A single European currency for EQ-5D health states, European J. Health Economics, 4, 3, 222-231, 2003.
37. Dolan P and Stalmeier P, The validity of time trade-off values in calculating QALYs: Constant proportional trade-off versus the proportional heuristic, J. Health Economics, 22, 445-458, 2003.
38. Dolan P, Olsen JA, Menzel P and Richardson J, An inquiry into the different perspectives that can be used to elicit preferences to inform priority-setting, Health Economics, 12, 7, 545-551, 2003.
39. Dolan P and Tsuchiya A, The person trade-off and the transitivity principle: an example from preferences over age weighting, Health Economics, 12, 6, 505-510, 2003.
40. Olsen JA, Richardson J, Dolan P, and Menzel P, The moral relevance of personal characteristics in setting health care priorities, Social Science and Medicine, 57, 1163-1172, 2003.
41. Tsuchiya A, Dolan P and Shaw R, Measuring people’s preferences regarding ageism in health: some methodological issues and some fresh evidence, Social Science and Medicine, 57, 687-696, 2003.
42. Dolan P and Shaw R, A note on the relative importance that people attach to different factors when setting priorities in health care, Health Expectations, 6, 1, 53-59, 2003.
43. Dolan P and Edlin R, Is it really possible to build a bridge between cost-benefit analysis and cost-effectiveness analysis?, J. Health Economics. 827-843, 2002.
44. Menzel P, Dolan P, Olsen JA and Richardson J, Adaptation to disability and the problem of perspective,Social Science and Medicine, 55, 12, 2149-2158, 2002.
45. Dolan P and Roberts J, Modelling valuations for EQ-5D health states: an alternative model using differences in valuations, Medical Care, 21, 2, 271-292, 2002.
46. Dolan P and Robinson A, The measurement of preferences over the distribution of benefits: The importance of the reference point, European Economic Review, 45, 9, 1697-1709, 2001.
47. Dolan P and Olsen JA, Equity in health: the importance of different health streams, J. Health Economics. 20, 823-834, 2001.
48. Dolan P and Roberts J, To what extent can we explain time trade-off values from other information about respondents?, Social Science and Medicine, 54, 6, 919-929, 2001.
49. Dolan P, Utilitarianism and the measurement and aggregation of QALYs, Health Care Analysis, 9, 65-76, 2001.
50. Cookson R and Dolan P, Principles of justice in rationing health care, J. Medical Ethics, 26, 323-329, 2000.
51. Dolan P, QALYs versus HYEs: health states versus health profiles, International J. Technology Assessment in Health Care, 16, 4, 1220-1224, 2000.
52. Dolan P and Cookson R, A qualitative study of the extent to which health gain matters when choosing between groups of patients, Health Policy, 51, 19-30, 2000.
53. Dolan P, The effect of age on health state valuations, J. Health Services Research and Policy, 5, 17-21, 2000.
54. Dolan P, Valuing health-related quality of life: issues and controversies, Pharmaco-Economics, 15, 119-127, 1999.
55. Cookson R and Dolan P, Public views on health care rationing: a group discussion study, Health Policy, 49, 63-74, 1999.
56. Dolan P, Cookson R and Ferguson B, The effect of group discussions on the public’s views regarding priorities in health care, British Medical J., 318, 916-919, 1999.
57. Dolan P and Torgerson D, The health-related quality-of-life of colles fracture patients, Osteoporosis International, 9, 196-199, 1999.
58. Dolan P, Torgerson D and Wolstenholme J, Costs of breast cancer treatment in the UK, The Breast, 8, 205-207, 1999.
59. Dolan P, Whose preferences count?, Medical Decision Making, 19, 482-486, 1999.
60. Dolan P, The measurement of individual utility and social welfare, J. Health Economics, 39-52, 1998.
61. Beattie J, Covey J, Dolan P, Hopkins L, Jones-Lee M, Loomes G, Pidgeon N, Robinson A and Spencer A, The contingent valuation of safety and the safety of contingent valuation, J. Risk and Uncertainty, 1998.
62. Dolan P and Green C, Using the person trade-off approach to examine differences between individual and social values, Health Economics, 7, 307-312, 1998.
63. Kind P, Dolan P, Gudex C and Williams A, Variations in population health status: results from a UK survey, British Medical J., 316, 736-741, 1998.
64. Dolan P and Torgerson D, The cost of treating osteoporotic fractures in the UK female population,Osteoporosis International, 8, 611-617, 1998.
65. Torgerson D and Dolan P, Prescribing by general practitioners after an osteoporotic fracture, Annals of rheumatic Diseases, 57, 378-379, 1998.
66. Dolan P and Jones-Lee MW, The time trade-off: a note on lifetime reallocation of consumption and discounting, J. Health Economics, 16, 6, 371-379, 1997.
67. Dolan P, Modelling valuations for health states, Medical Care, 11, 1095-1108, 1997.
68. Robinson A, Dolan P and Williams A, Valuing health states using VAS and TTO: what lies behind the numbers?, Social Science and Medicine, 45, 1289-1297, 1997.
69. Dolan P and Sutton M, Mapping visual analogue scale scores onto time trade-off and standard gamble utilities, Social Science and Medicine, 44, 10, 1519-1530, 1997.
70. Dolan P, Aggregating health state valuations, J. Health Services Research and Policy, 2, 160-165, 1997.
71. Gudex C, Dolan P, Kind P and Williams A, Health state valuations from the general public using the visual analogue scale, Quality of Life Research, 5, 521-531, 1997.
72. Gudex C, Dolan P, Kind P and Williams A, Valuing health states: interviews with the general public:European J. Public Health, 7, 441-448, 1997.
73. Dolan P, The nature of individual preferences, Health Economics, 6, 91-93, 1997.
74. Chetter I, Dolan P, Spark J, Scott D and Kester R, Quality of life analysis in patients with lower limb ischaemia, European Jorunal of Vascular Surgery, 13, 597-604, 1997.
75. Chetter I, Dolan P, Spark J, Scott D and Kester R, Correlating clinical indicators of lower-limb iscaemia with QoL, Cardiovascular Surgery, 5, 361-366, 1997.
76. Dolan P, Gudex C, Kind P and Williams A, Valuing health states: a comparison of methods, J. Health Economics, 15, 209-231, 1996.
77. Dolan P, Gudex C, Kind P and Williams A, The time trade-off method: results from a general population study, Health Economics, 5, 141-154, 1996.
78. Dolan P and Kind P, Inconsistencies and health state valuations, Social Science and Medicine., 42, 4, 609-615, 1996.
79. Dolan P, Modelling values for EuroQol health states: the effect of duration, Health Policy, 38, 189-203, 1996.
80. Dolan P, The effect of experience of illness on health state valuations, J. Clinical Epidemiology, 49, 551-564, 1996.
81. Dolan P, Jones-Lee MW and Loomes GC, Risk-risk versus standard gamble procedures for measuring health state utilities, Applied Economics, 27, 1103-1111, 1995.
82. Dolan P and Gudex C, Time Preference, duration and health state valuations, Health Economics, 4, 289-299, 1995.
83. Kind P and Dolan P, The effect of past and present illness experience on health state valuations,Medical Care, 33(4), AS255-AS263, 1995.
White M, Dolan P, 2009, Accounting for the richness of our daily activities
et al., 2009, Valuing health directly, Bmj-british Medical Journal, Vol:339, ISSN:1756-1833
Dolan P, Tsuchiya A, 2009, The social welfare function and individual responsibility: Some theoretical issues and empirical evidence (vol 28, pg 210, 2009), Journal of Health Economics, Vol:28, ISSN:0167-6296, Pages:758-759
et al., 2009, Examining the attitudes and preferences of health care decision-makers in relation to access, equity and cost-effectiveness: A discrete choice experiment, Health Policy, Vol:90, ISSN:0168-8510, Pages:45-57